Belgium: Gimv raises €247m from rights issue

Belgium-based private equity firm, Gimv, has completed the first phase of its rights issue resulting in a take-up of 82.5% of the new shares. An accelerated...

Switzerland: BioVersys shares begin trading on SIX Swiss

BioVersys, a Switzerland-based multi-asset, clinical stage biopharmaceutical company focusing on R&D of novel antibacterial products, has priced its IPO at CHF36 per share, implying...

Germany: Lauxera invests in German neurovascular medical device company

France-based international healthcare-focused asset management company Lauxera Capital Partners has invested in Acandis, a German neurovascular medical device company dedicated to the prevention and...

Sweden: Safe Life adds to portfolio with acquisition of Life Safety Solutions

Safe Life, a Stockholm-based provider of life-saving solutions with portfolio companies across Europe and North America, has acquired US-based Life Safety Solutions, a provider of life safety equipment...

France: Proteor expands digital solutions with Filament Innovations

Proteor, a France-based developer of prostheses, orthoses, orthopedic components and application software, has acquired Filament Innovations, a US-based designer and manufacturer of 3D printing...

UK: Liva Healthcare acquires Discover Momenta and secures new backing

Liva Healthcare, a digital health technology platform delivering best-in-class outcomes for lifestyle-related chronic diseases, has acquired UK-based Discover Momenta, including subsidiary Momenta Newcastle, for...

UK: Asker Healthcare acquires HSL from Foresight

Asker Healthcare Group, a Sweden-based provider of medical products and solutions has acquired Northern Ireland-based Hospital Services Limited (HSL), alongside HSL management, from Foresight...

Poland: MidEuropa raises over US$400m from Diagnostyka IPO

Diagnostyka, a provider of diagnostic services with the largest network of medical laboratories and blood collection points in Poland, has priced its all secondary...

Australia: AdvanCell completes oversubscribed US$112m Series C

Australia-based clinical-stage radiopharmaceutical company, AdvanCell, a developer of cancer therapeutics, has completed an oversubscribed US$112m Series C financing. The funding round was co-led by SV...

UK: Knight Frank advises on sale of UK care home portfolio [update]

Knight Frank’s Healthcare team has advised North Bay Group on the sale of a portfolio of six care homes across the North of England...
Advertisement